Everything is much bigger on planet PEB.
Printable View
Indeed!
Best example of planet PEB : https://www.nzx.com/files/attachments/267494.pdf
Page 8 - Lab throughputs
FY14 - 168
FY15 - 3910
Chris Swann in Dec 2013 : "Several tens of thousands of tests" in 2014! Guess that means at least 30,000?
Note : Lab throughput included user programmes and commercial tests!
https://www.nzx.com/companies/PEB/announcements/308860
"Team punches well above its weight in the global market' - PEB sure does! $7.5m of salaries for top 35 executives last year to produce $20m loss and no tangible progress on the 'transformative' customers!
And of course, in PEB's parallel universe, 168 plus 3910 tests = several tens of thousands!
In PEB's parallel universe, 16 years = 2.17 years so PEB is in its infancy (you need to do the maths with actual vs 'several tens of thousands of tests')
He will indeed be beside himself with transformative excitement at pursuing the 'high growth' opportunities after being identified as a TIN(pot) company!
More user programs in the pipeline to boost the test numbers?
Observe the underwriter's gallant attempt to dress up this morning's opening quotes to open at 34c?
Presumably underwriter (as only a prize buffoon) would pay up to get stock at 34c knowing full well there will be plenty of selling at 33c at least.
Maybe underwriter is feeling sorry for long suffering PEB shareholders so giving some who are not intending to put in any more money to make 2c by selling at 34c and buying back via the rights at 32c.
6.25% return over a month is not a bad return!
Oops - wrote too soon. Stock being offered now at 33c and underwriter has retreated to 32.5c? Hardly worth the hassle now.
FNZC in their wildest most pessimistic dreams would not have picked a 30% drop in share price from the rights issue announcement. What's wrong with investors? Do they not know a good high growth company recognized by TIN (pot)?
FNZC normally would lay off some of the underwriting risk with sub-underwriters, principally the large existing institutional shareholders like Salt & Devon. In return, the institutions who participate get a cut of the underwriting fees and first shot at taking up the shortfall by being invited to participate in bidding for the shortfall.
What could be different this time is that some of the institutional shareholders did not participate in the last capital raise (eg, Tindall) so are unlikely to this time round.
So FNZC could end up sucking on this one although they have done well out of the last 2 capital raisings.
I suppose with their underwriters fee of $2 million?? (don't know how much it is but presume it would have to be a lot, can someone clarify) they would have a bit of a buffer if things turned south. Still they could end up with a lot of stock that they do not really want. Does the house hold the stock as a long term investor or will they be looking to sell it all and get rid of it?